Bioorganic and Medicinal Chemistry Letters, volume 29, issue 10, pages 1246-1255

Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA

Beloglazkina Elena K
Uspenskaya Anastasia A
Skvortsov Dmitry A.
Garanina Anastasia S
Zyk Nikolay V. 2
Vorobyeva Nataliya S 3
Machulkin Alexey E. 2
Deyneka Ekaterina V. 4
Trofimenko Alexander V. 4
Koteliansky Victor E. 2
Bezrukov Dmitry S.
Puchinina Maria M. 4
Riabykh Grigory K 2
Sofronova Alina A. 5
Malyshev Alexander S. 6
Garanina A. S. 7, 8
Bezrukov Dmitry S. 8, 9
Aladinskaya Anastasia V. 4
Publication typeJournal Article
Publication date2019-05-01
Quartile SCImago
Q2
Quartile WOS
Q2
Impact factor2.7
ISSN0960894X, 14643405
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Pharmaceutical Science
Clinical Biochemistry
Molecular Medicine
Abstract
Prostate-specific membrane antigen (PSMA), also known as glutamate carboxypeptidase II (GCPII), has recently emerged as a prominent biomarker of prostate cancer (PC) and as an attractive protein trap for drug targeting. At the present time, several drugs and molecular diagnostic tools conjugated with selective PSMA ligands are actively evaluated in different preclinical and clinical trials. In the current work, we discuss design, synthesis and a preliminary biological evaluation of PSMA-specific small-molecule carrier equipped by Doxorubicin (Dox). We have introduced an unstable azo-linker between Dox and the carrier hence the designed compound does release the active substance inside cancer cells thereby providing a relatively high Dox concentration in nuclei and a relevant cytotoxic effect. In contrast, we have also synthesized a similar conjugate with a stable amide linker and it did not release the drug at all. This compound was predominantly accumulated in cytoplasm and did not cause cell death. Preliminary in vivo evaluation has showed good efficiency for the degradable conjugate against PC3-PIP(PSMA+)-containing xenograft mine. Thus, we have demonstrated that the conjugate can be used as a template to design novel analogues with improved targeting, anticancer activity and lower rate of potential side effects. 3D molecular docking study has also been performed to elucidate the underlying mechanism of binding and to further optimization of the linker area for improving the target affinity.

Citations by journals

1
Bioorganic and Medicinal Chemistry Letters
Bioorganic and Medicinal Chemistry Letters, 1, 5.88%
Bioorganic and Medicinal Chemistry Letters
1 publication, 5.88%
Molecules
Molecules, 1, 5.88%
Molecules
1 publication, 5.88%
Mendeleev Communications
Mendeleev Communications, 1, 5.88%
Mendeleev Communications
1 publication, 5.88%
Natural Product Communications
Natural Product Communications, 1, 5.88%
Natural Product Communications
1 publication, 5.88%
Journal of Molecular Structure
Journal of Molecular Structure, 1, 5.88%
Journal of Molecular Structure
1 publication, 5.88%
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 1, 5.88%
Journal of Medicinal Chemistry
1 publication, 5.88%
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 1, 5.88%
European Journal of Medicinal Chemistry
1 publication, 5.88%
Biophysical Reviews
Biophysical Reviews, 1, 5.88%
Biophysical Reviews
1 publication, 5.88%
Acta Pharmaceutica Sinica B
Acta Pharmaceutica Sinica B, 1, 5.88%
Acta Pharmaceutica Sinica B
1 publication, 5.88%
Journal of Materials Chemistry B
Journal of Materials Chemistry B, 1, 5.88%
Journal of Materials Chemistry B
1 publication, 5.88%
Nanoscale
Nanoscale, 1, 5.88%
Nanoscale
1 publication, 5.88%
ChemMedChem
ChemMedChem, 1, 5.88%
ChemMedChem
1 publication, 5.88%
Expert Opinion on Therapeutic Patents
Expert Opinion on Therapeutic Patents, 1, 5.88%
Expert Opinion on Therapeutic Patents
1 publication, 5.88%
Nano Research
Nano Research, 1, 5.88%
Nano Research
1 publication, 5.88%
Bioorganic Chemistry
Bioorganic Chemistry, 1, 5.88%
Bioorganic Chemistry
1 publication, 5.88%
Chemical and Pharmaceutical Bulletin
Chemical and Pharmaceutical Bulletin, 1, 5.88%
Chemical and Pharmaceutical Bulletin
1 publication, 5.88%
1

Citations by publishers

1
2
3
4
5
6
Elsevier
Elsevier, 6, 35.29%
Elsevier
6 publications, 35.29%
Springer Nature
Springer Nature, 2, 11.76%
Springer Nature
2 publications, 11.76%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 2, 11.76%
Royal Society of Chemistry (RSC)
2 publications, 11.76%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 1, 5.88%
Multidisciplinary Digital Publishing Institute (MDPI)
1 publication, 5.88%
SAGE
SAGE, 1, 5.88%
SAGE
1 publication, 5.88%
American Chemical Society (ACS)
American Chemical Society (ACS), 1, 5.88%
American Chemical Society (ACS)
1 publication, 5.88%
Wiley
Wiley, 1, 5.88%
Wiley
1 publication, 5.88%
Taylor & Francis
Taylor & Francis, 1, 5.88%
Taylor & Francis
1 publication, 5.88%
Pharmaceutical Society of Japan
Pharmaceutical Society of Japan, 1, 5.88%
Pharmaceutical Society of Japan
1 publication, 5.88%
1
2
3
4
5
6
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Ivanenkov Y. et al. Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA // Bioorganic and Medicinal Chemistry Letters. 2019. Vol. 29. No. 10. pp. 1246-1255.
GOST all authors (up to 50) Copy
Machulkin A. E., Majouga A. G., Malyshev A. S., Sofronova A. A., Riabykh G. K., Puchinina M. M., Vorobyeva N. S., V. Aladinskaya A., Bezrukov D. S., Koteliansky V. E., Zyk N. V., Beloglazkina E. K., Trofimenko A. V., Deyneka E. V., Uspenskaya A. A., Skvortsov D. A., Garanina A. S., Ivanenkov Y., Garanina A. S., Skvortsov D., Uspenskaya A. A., Beloglazkina E. K., Bezrukov D. S., Aladinskaya A. V. Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA // Bioorganic and Medicinal Chemistry Letters. 2019. Vol. 29. No. 10. pp. 1246-1255.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.bmcl.2019.01.040
UR - https://doi.org/10.1016%2Fj.bmcl.2019.01.040
TI - Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA
T2 - Bioorganic and Medicinal Chemistry Letters
AU - Ivanenkov, Yan
AU - Machulkin, Alexey E.
AU - Garanina, Anastasia S
AU - Skvortsov, Dmitry A.
AU - Uspenskaya, Anastasia A
AU - Deyneka, Ekaterina V.
AU - Trofimenko, Alexander V.
AU - Beloglazkina, Elena K
AU - Zyk, Nikolay V.
AU - Koteliansky, Victor E.
AU - Bezrukov, Dmitry S.
AU - V. Aladinskaya, Anastasia
AU - Vorobyeva, Nataliya S
AU - Puchinina, Maria M.
AU - Riabykh, Grigory K
AU - Sofronova, Alina A.
AU - Malyshev, Alexander S.
AU - Majouga, Alexander G.
AU - Garanina, A. S.
AU - Skvortsov, Dmitry
AU - Uspenskaya, Anastasia A.
AU - Beloglazkina, Elena K.
AU - Bezrukov, Dmitry S.
AU - Aladinskaya, Anastasia V.
PY - 2019
DA - 2019/05/01 00:00:00
PB - Elsevier
SP - 1246-1255
IS - 10
VL - 29
SN - 0960-894X
SN - 1464-3405
ER -
BibTex |
Cite this
BibTex Copy
@article{2019_Ivanenkov,
author = {Yan Ivanenkov and Alexey E. Machulkin and Anastasia S Garanina and Dmitry A. Skvortsov and Anastasia A Uspenskaya and Ekaterina V. Deyneka and Alexander V. Trofimenko and Elena K Beloglazkina and Nikolay V. Zyk and Victor E. Koteliansky and Dmitry S. Bezrukov and Anastasia V. Aladinskaya and Nataliya S Vorobyeva and Maria M. Puchinina and Grigory K Riabykh and Alina A. Sofronova and Alexander S. Malyshev and Alexander G. Majouga and A. S. Garanina and Dmitry Skvortsov and Anastasia A. Uspenskaya and Elena K. Beloglazkina and Dmitry S. Bezrukov and Anastasia V. Aladinskaya},
title = {Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA},
journal = {Bioorganic and Medicinal Chemistry Letters},
year = {2019},
volume = {29},
publisher = {Elsevier},
month = {may},
url = {https://doi.org/10.1016%2Fj.bmcl.2019.01.040},
number = {10},
pages = {1246--1255},
doi = {10.1016/j.bmcl.2019.01.040}
}
MLA
Cite this
MLA Copy
Ivanenkov, Yan, et al. ā€œSynthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA.ā€ Bioorganic and Medicinal Chemistry Letters, vol. 29, no. 10, May. 2019, pp. 1246-1255. https://doi.org/10.1016%2Fj.bmcl.2019.01.040.
Found error?